Sign Up to like & get
recommendations!
0
Published in 2020 at "Molecular pharmaceutics"
DOI: 10.1021/acs.molpharmaceut.0c00008
Abstract: Prodrug‒carboxypeptidase G2 (e.g., ZD2767P+CPG2) can realize a targeted treatment where the specific advantage is a lack of CPG2 analogs in humans, but it is limited by low efficacy. Here ultrasound was employed to enhance ZD2767P+CPG2…
read more here.
Keywords:
cpg2;
ovarian cancer;
cancer cells;
zd2767p cpg2 ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2019 at "Molecular psychiatry"
DOI: 10.1038/s41380-018-0314-z
Abstract: Bipolar disorder (BD) is a common mood disorder characterized by recurrent episodes of mania and depression. Both genetic and environmental factors have been implicated in BD etiology, but the biological underpinnings remain elusive. Recently, genome-wide…
read more here.
Keywords:
protein;
disorder;
cpg2;
expression ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2019 at "Neuro-Oncology"
DOI: 10.1093/neuonc/noz126.353
Abstract: CPG2 is an efficient rescue recombinant bacterial enzyme that cleaves MTX into inactive metabolites. As hdMTX is the key agent in PCNSL, delayed MTX excretion (DME), and/or MTX induced nephrotoxicity (MIN) may expose the patients…
read more here.
Keywords:
loc network;
cpg2;
study;
rescue ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2023 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2023.1003633
Abstract: Introduction Glucarpidase (CPG2) reduces the lethal toxicity of methotrexate (MTX) by rapid degradation. Methods In this study, a CPG2 population pharmacokinetics (popPK) analysis in healthy volunteers (phase 1 study) and a popPK-pharmacodynamics (popPK-PD) analysis in…
read more here.
Keywords:
cpg2;
mtx;
methotrexate;
population pharmacokinetics ... See more keywords